East Bay's Scribe Therapeutics lands 2nd big deal with Sanofi, this one aimed initially at sickle cell disease
San Francisco Business Times
|
July 18, 2023
X min read
San Francisco Business Times
|
July 18, 2023
Share on Social
More like this
News
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
Press
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
